- Companies
- AcuityMD
AcuityMD Valuation, Funding & Investors
AcuityMD is valued at $955M as of April 2026.
Last AcuityMD valuation
$955M
Series C · Apr 2026
Last AcuityMD funding round
$80M
Series C · Apr 2026
Cumulative funding AcuityMD raised
$163M
across 4 funding rounds
Key investors in AcuityMD
Benchmark
Redpoint
ICONIQ Capital
StepStone Group
Atreides Management
Ajax Health
About AcuityMD
AcuityMD is a software platform that aggregates clinical utilization data to accelerate medical device commercialization for orthopedics and spine companies. Boston-headquartered, it analyzes procedure volumes and surgeon preferences from electronic health records across U.S. hospitals. The platform equips sales teams with market intelligence on over 10 million procedures, enabling targeted account planning and evidence-based launches.
Founded
2019
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Subscription
Valuation
$955M (Apr 2026)
AcuityMD Valuation
AcuityMD is currently valued at $955M, based on its Series C in April 2026.
The $80M round was led by StepStone Group, with participation from Redpoint, ICONIQ Capital, Atreides Management and Benchmark.
AcuityMD valuation by funding round
| Date | Stage | Valuation |
|---|---|---|
| Apr 2026 | Series C | $955M |
AcuityMD Funding History
AcuityMD has raised a total of $163M across 4 funding rounds.
AcuityMD's first fundraising round was a $7M seed round in May 2021. The most recent completed round was a $80M Series C in April 2026.
AcuityMD funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Apr 2026 | Series C | StepStone Group (lead); Redpoint; ICONIQ Capital; Atreides Management; Benchmark | $80M | $955M | AcuityMD, an AI platform for the medical device and medtech industry based in Boston, raised $80 million in Series C funding in April 2026. The round was led by existing investor StepStone Group, with participation from Benchmark, Redpoint Ventures, ICONIQ Capital, and Atreides Management. The funding pushed the company's post-money valuation to $955 million, bringing total capital raised to over $160 million since inception in 2019. The company previously raised a Series A in 2022 and a $45 million Series B in 2024. AcuityMD's platform serves 16 of the top 20 medtech companies and has helped customers identify over $34 billion in pipeline value. The new capital will fund three strategic priorities: accelerating agentic AI capabilities for commercial personas including sales representatives, leadership, and marketing teams; deepening the MedTech ontology powering the company's data model; and expanding the platform beyond commercial applications across the full product lifecycle. |
| Jun 2024 | Series B | ICONIQ Capital (lead); Redpoint; StepStone Group; Atreides Management; Artisanal Ventures; Benchmark | $45M | - | AcuityMD, a Boston-based provider of a commercial intelligence platform for medical technology (MedTech) manufacturers, announced a $45 million Series B funding round on June 4, 2024, led by ICONIQ Growth with participation from Atreides Management, StepStone Group, and existing investors Redpoint Ventures, Benchmark Capital, and Artisanal Ventures. The round brings total funding to over $83 million. The platform compiles healthcare data including physician procedural volumes, product preferences, sites of care affiliations, peer networks, and referral patterns into workflows and recommendations, supporting over 200 MedTech manufacturers, including six of the top 10, and ranked in the top quartile for customer retention and growth among B2B software companies per ICONIQ Growth analysis. The funding will expand the platform, launch three new products to general availability, broaden the pipeline management solution, and grow engineering and product teams by 70% by end of 2024 to accelerate MedTech adoption. Since the 2022 Series A, AcuityMD achieved a 10x increase in annual recurring revenue (ARR), with top sales reps seeing over 25% growth and over $10 billion in opportunity pipeline created. ICONIQ Growth highlighted AcuityMD's data-driven insights and potential as a complete commercial operating system for MedTech, drawing parallels to investments like Komodo Health and Benchling. Founded in 2019, AcuityMD addresses MedTech challenges in targeting doctors and product performance tracking by combining claims data, sales data, pricing, and territory alignment into modules for markets assessment, territory management, targeting, pipeline tracking, and contracts optimization. The company benefits from a healthcare advisory council with executives from Johnson & Johnson, Stanford Healthcare, and Cleveland Clinic. |
| May 2022 | Series A | Redpoint (lead); Artisanal Ventures; Benchmark; Ajax Health | $31M | - | AcuityMD, a commercial intelligence platform for the MedTech industry, raised $31 million in a Series A funding round on May 12, 2022, led by Redpoint Venture Partners with participation from Benchmark, Ajax Health, and Artisanal Ventures. The funding aimed to expand its software that helps medical device companies identify new sales opportunities and accelerate commercialization. Since its seed round in May 2021, AcuityMD's platform had enabled medtech customers to identify over 40,000 new opportunities, translating to over $2 billion in new annual pipeline value. Customers including Anika Therapeutics, Cordis, and Olympus used the tool to gain analytics, procedural insights, and market intelligence in the nearly half-trillion-dollar medical device industry. The platform addresses gaps in go-to-market strategies for MedTech firms by providing targeting capabilities that uncover opportunities and track product users. Redpoint's Logan Bartlett highlighted AcuityMD's potential to streamline sales and grow businesses in this underserved sector. AcuityMD operates in a growing medical devices market valued at $512.2 billion in 2022, projected to reach $799.6 billion by 2030, and the business intelligence space estimated at $27.1 billion in 2022. |
| May 2021 | Seed | Benchmark (lead); Spearhead; Ajax Health | $7M | - | AcuityMD is an enterprise software platform for commercializing and improving medical devices with data. Founded in 2019 by Mike Monovoukas, Lee Smith, and Robert Coe, the company operates a data platform that breaks down information silos in the medical device industry, connecting product-level data across manufacturers, healthcare providers, and insurance companies to surface insights about device performance and patient outcomes. In May 2021, AcuityMD closed a $7 million seed financing round led by Benchmark Capital with participation from Ajax Health. Eric Vishria, a General Partner at Benchmark, joined AcuityMD's board as part of the investment. The company planned to use the capital to accelerate hiring with the goal of doubling its eight-person team by year-end 2021 and to invest in product development. At the time of the funding, AcuityMD had been operating commercially for approximately one year and had tailored its platform to serve multiple medical device verticals including orthopaedics, spine, biologics, surgical imaging, and endoscopy. |
Who has invested in AcuityMD?
8 investors have backed AcuityMD across its funding rounds, including Benchmark, Redpoint, ICONIQ Capital, StepStone Group, Atreides Management and Ajax Health.
Lead investors include StepStone Group, ICONIQ Capital, Redpoint and Benchmark.
AcuityMD Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 4 | Lead | May 2021 | ||
| 3 | Lead | May 2022 | ||
| 2 | Lead | Jun 2024 | ||
| 2 | Lead | Jun 2024 | ||
| 2 | Participant | Jun 2024 | ||
| 2 | Participant | May 2022 | ||
This data is available for Pro users. Sign up to see all 8 AcuityMD investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAcuityMD Competitors
AcuityMD competitors include listed companies like MedicalSystem Technology and PHC Holdings, and private ones like Dental Monitoring, BrightInsight, Capsule and DocPlanner.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | $91M | - | $1B | - | ||
| Publicly listed | $45M | $12M | $889M | 15.6x | ||
| Publicly listed | $2.3B | $320M | $1.1B | 1.0x | ||
| Private | - | - | $750M | - | ||
| Private | - | - | $1B | - | ||
| Private | - | - | $1B | - |
AcuityMD Public Comps
AcuityMD is still privately-owned, but its public comps include CeriBell, Mani Inc., iFLYHealth, HealthStream, Shanghai Haohai, MedicalSystem Technology, Enovis, Vitec Software, Bioventus and Wandong Medical.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $89M | ($50M) | 9.6x | 7.9x | (17.0x) | (14.2x) | |||
| $193M | $60M | 4.0x | 3.6x | 12.9x | 9.7x | |||
| $136M | ($7M) | 7.7x | 6.2x | (150.8x) | (144172.5x) | |||
| $304M | $63M | 2.8x | 2.6x | 13.2x | 11.2x | |||
| $365M | $59M | 1.7x | 1.8x | 10.6x | 10.1x | |||
| $45M | $12M | 18.9x | 15.6x | 70.7x | 62.9x | |||
| $2.2B | ($830M) | 1.1x | 1.0x | (2.9x) | 5.7x | |||
| $371M | $151M | 3.7x | 3.5x | 9.1x | 9.0x | |||
This data is available for Pro users. Sign up to see all AcuityMD competitors and their valuation data. Start Free Trial | ||||||||
Common questions about AcuityMD
| When was AcuityMD founded? | AcuityMD was founded in 2019. |
| Where is AcuityMD headquartered? | AcuityMD is headquartered in Boston, MA, United States. |
| Is AcuityMD publicly listed? | No, AcuityMD is a private, VC-backed company. |
| What is AcuityMD's valuation? | AcuityMD was last valued at $955M in its Series C in April 2026. |
| How much funding has AcuityMD raised? | AcuityMD has raised $163M across 4 funding rounds. |
| What was AcuityMD's last funding round? | AcuityMD's last funding round was a $80M Series C in April 2026, led by StepStone Group. |
| Who are AcuityMD's investors? | AcuityMD's investors include Benchmark, Redpoint, ICONIQ Capital, StepStone Group, Atreides Management, Artisanal Ventures, Ajax Health and Spearhead. |
| Which companies are comparable to AcuityMD? | Companies comparable to AcuityMD include Dental Monitoring, MedicalSystem Technology, PHC Holdings, BrightInsight, Capsule and DocPlanner. |
See companies similar to AcuityMD
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




